Arcadia Biosciences Inc Overview
Industry: Packaged Foods
Sector: Consumer Defensive
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, be Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Arcadia Biosciences Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $1.4M (-1% YoY).
What changed
- Revenue -1% YoY to $1.4M.
Guidance / outlook
we expect to accelerate as a result of new products we are bringing to market.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Arcadia Biosciences earnings missed by $1.53, revenue fell short of estimates
Headline from Investing.com: Arcadia Biosciences earnings missed by $1.53, revenue fell short of estimates.
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com
Headline from Investing.com Australia: Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com.
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com
Headline from Investing.com India: Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com.
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com
Headline from Investing.com Canada: Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com.
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Headline from GlobeNewswire: Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.